Maryline Barrié - Concepedia

Author

Maryline Barrié

Also Known As

F. Lafitte, M Barrie, M T Barrie, M. Barrie, M. Barrié, MARYLINE BARRIE, Maryline Barrie, Maryline Barrié, Michael T. Barrie

109

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Hôpital de la Timone Aix-Marseille Université Sorbonne Université Inserm Pitié-Salpêtrière Hospital

About

Maryline Barrié is an author at Hôpital de la Timone specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Health Sciences	5	5	183
3	Social Sciences	1	1	44
4	Behavioral Health	1	1	44
5	Cellular Therapies	1	1	43

Maryline Barrié

Publications

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy for Glioblastoma in the Elderly Florence Keime-Guibert, Olivier Chinot, Luc Taillandier, New England Journal of Medicine	2007	774
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network Carole Soussain, Sylvain Choquet, Marie Blonski, European Journal of Cancer Neuro-oncologyPrimary Vitreoretinal LymphomaLymphoid NeoplasiaOphthalmologyMedicine	2019	305
Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial Jaime Gállego Pérez‐Larraya, François Ducray, Olivier Chinot, Journal of Clinical Oncology	2011	206
Correlation Between O<sup>6</sup>-Methylguanine-DNA Methyltransferase and Survival in Inoperable Newly Diagnosed Glioblastoma Patients Treated With Neoadjuvant Temozolomide Olivier Chinot, Maryline Barrié, S. Fuentès, Journal of Clinical Oncology	2007	203
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial Antonio Omuro, Olivier Chinot, Luc Taillandier, The Lancet Haematology Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaIntergroup Anocef-goelamsMedicine	2015	199
Safety and Efficacy of Temozolomide in Patients With Recurrent Anaplastic Oligodendrogliomas After Standard Radiotherapy and Chemotherapy Olivier Chinot, Stéphane Honoré, Henry Dufour, Journal of Clinical Oncology	2001	176
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations Olivier Chinot, Maryline Barrié, Élisabeth Frauger, Cancer	2004	138
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly Antonio Omuro, Luc Taillandier, Olivier Chinot, Journal of Neuro-Oncology Neuro-oncologyLymphoid NeoplasiaMedicinePathologyPharmacology	2007	136
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial Thomas Graillon, Marc Sanson, Chantal Campello, Clinical Cancer Research	2020	135
Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients P. Métellus, Jacques Guyotat, Olivier Chinot, Neuro-Oncology Neuro-oncologyEpendymomas AccountSurgical OncologyIi EpendymomasPrognostic Factor Analysis	2010	88

Page 1